Related Experiment Video
Updated: Aug 13, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
[Beware of yeast septicemia in intensive care medicine]
M A Dhahri1, A Jebali, K Lamine
1Département d'Anesthésie-Réanimation de l'Hôpital Militaire de Tunis, Montfleury, Tunisie.
Abstract:
A retrospective study of 24 cases of systemic candidosis observed in a polyvalent intensive care unit over a 6.5 yr period (1987-1993) led to some constatations: an increasingly high incidence of this type of septicaemia (up to 27.5% of all septicaemias), large responsibility of skin saprophytes Candida ( > 62% vs 21% from intestinal Candida albicans), frequent diagnostic difficulties, and a fatal outcome in 7/24 patients (mainly from severe causal illness). In order to improve the prognosis, a more systematic and often empirical resort to fungicidal agents could be justified whenever patients with very severe surgical or medical conditions develop a protracted fever of unclear origin.
Insights
Systemic candidosis, a serious bloodstream infection, is increasingly common in intensive care units. Skin fungi, not gut Candida albicans, are the main culprits, often leading to difficult diagnoses and poor outcomes.
Area of Science:
- Infectious Diseases
- Mycology
- Critical Care Medicine
Context:
- Retrospective analysis of 24 systemic candidosis cases over 6.5 years in a polyvalent intensive care unit (ICU).
- Observed incidence of candidal septicaemia up to 27.5% of all ICU septicaemias.
- High prevalence of non-albicans Candida species, particularly skin saprophytes, as causative agents.
Purpose:
- To analyze the incidence, causative agents, diagnostic challenges, and outcomes of systemic candidosis in an ICU setting.
- To identify key factors contributing to the high mortality rate.
- To inform strategies for improving patient prognosis.
Summary:
- Systemic candidosis incidence is rising in ICUs, with skin Candida species being more frequently implicated than Candida albicans.
- Diagnostic difficulties are common, and the mortality rate remains significant (7/24 patients), often linked to severe underlying conditions.
- A significant proportion of septicaemia cases (up to 27.5%) were attributed to Candida infections.
Impact:
- Highlights the increasing threat of systemic candidosis in critical care environments.
- Emphasizes the need for improved diagnostic approaches and targeted antifungal therapy.
- Suggests empirical antifungal treatment may be warranted for critically ill patients with persistent fever of unknown origin to improve outcomes.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Cryptococcal Meningitis

